+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5665849
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopharmaceuticals Market grew from USD 574.04 billion in 2023 to USD 627.19 billion in 2024. It is expected to continue growing at a CAGR of 9.74%, reaching USD 1.10 trillion by 2030.

The biopharmaceutical market, encompassing biotechnologically-derived drugs, vaccines, and therapies, is pivotal within the healthcare sector due to its profound implications for treating diseases like cancer, diabetes, and autoimmune disorders. The necessity for biopharmaceuticals is underscored by an increasing global prevalence of chronic illnesses, aging populations, and a heightened focus on precision medicine. These products, largely produced using living organisms, are pivotal in enhancing patient outcomes through personalized treatment. The application of biopharmaceuticals spans various medical fields, including oncology, endocrinology, and neurology, with end-use scope extending to hospitals, clinics, and research institutions.

Key growth influencers include advancements in biotechnology, supportive government regulations, and significant investments in R&D by leading pharmaceutical companies. The shift towards biologics and biosimilars, due to their efficacy and reduced side effects, also fuels market expansion. Emerging markets and the rise of contract development and manufacturing organizations (CDMOs) present robust opportunities, as companies seek cost-effective production solutions. Collaborations between biotech firms and research organizations are recommended to leverage pipeline innovations and expedite drug discovery processes.

However, market growth faces limitations such as high research costs, complex manufacturing processes, and stringent regulatory frameworks, which can lead to significant delays in product launches. Additionally, the patent expiration of blockbuster biologics opens the market to biosimilar competition, potentially impacting revenues. Despite these challenges, promising areas for innovation include gene therapy, stem cell research, and monoclonal antibodies, all of which hold transformative potential for addressing unmet medical needs.

The biopharmaceutical market is characterized by rapid technological advancements and increasing competition. Companies are advised to invest in cutting-edge platforms, such as AI and machine learning, to optimize drug discovery and development. Moreover, enhancing supply chain resilience and focusing on sustainable practices will be crucial to navigate market dynamics effectively and maintain a competitive edge.

Understanding Market Dynamics in the Biopharmaceuticals Market

The Biopharmaceuticals Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of Chronic Diseases and Need for Targeted Biopharmaceuticals
    • Rising Investments in Vaccine and Drugs Development
    • Attractive Reimbursement Policies for Biopharmaceuticals
  • Market Restraints
    • Raw Material Supply Chain Disruptions and High Cost of Drug Development
  • Market Opportunities
    • Advancements in Biopharmaceutical Manufacturing and Testing Technologies
    • Emerging Trends of Outsourcing Biologics and Vaccine Manufacturing
  • Market Challenges
    • Stringent Regulatory Framework for Drug Manufacturing and Time-Consuming Clinical Trials

Exploring Porter’s Five Forces for the Biopharmaceuticals Market

Porter’s Five Forces framework further strengthens the insights of the Biopharmaceuticals Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Biopharmaceuticals Market

External macro-environmental factors deeply influence the performance of the Biopharmaceuticals Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Biopharmaceuticals Market

The Biopharmaceuticals Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biopharmaceuticals Market

The Biopharmaceuticals Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Avidea Technologies, Bayer AG, Thermo Fisher Scientific Inc., Ferring Pharmaceuticals, Abbott Laboratories, LG Chem Life Sciences Innovation Center, Inc., Ipsen Pharma, Novo Nordisk A/S, Amgen Inc., BTL Biotechno Labs Pvt. Ltd., Johnson & Johnson Services, Inc., Pfizer, Inc., bioMérieux SA, Nordic BioSite, GlaxoSmithKline PLC, Novartis AG, Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Sanofi S.A., Abgenex, AstraZeneca PLC, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, Bio-Techne Corporation, and Biogen Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Monoclonal Antibodies
    • Purified Proteins
    • Recombinant Growth Factors
    • Recombinant Hormone
    • Recombinant Proteins
    • Synthetic Immunomodulators
    • Vaccines
  • Services
    • Compendial & Multi Compendial Laboratory Testing
    • Custom Testing or Customer Proprietary Testing
    • Laboratory Testing
  • Raw Material Type
    • Active Pharmaceutical Ingredient
    • Formulation Excipients
  • Application
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Hormonal Disorders
    • Immunology
    • Inflammatory & Infectious Diseases
    • Metabolic Disorders
    • Neurological Diseases
    • Oncology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of Chronic Diseases and Need for Targeted Biopharmaceuticals
5.1.1.2. Rising Investments in Vaccine and Drugs Development
5.1.1.3. Attractive Reimbursement Policies for Biopharmaceuticals
5.1.2. Restraints
5.1.2.1. Raw Material Supply Chain Disruptions and High Cost of Drug Development
5.1.3. Opportunities
5.1.3.1. Advancements in Biopharmaceutical Manufacturing and Testing Technologies
5.1.3.2. Emerging Trends of Outsourcing Biologics and Vaccine Manufacturing
5.1.4. Challenges
5.1.4.1. Stringent Regulatory Framework for Drug Manufacturing and Time-Consuming Clinical Trials
5.2. Market Segmentation Analysis
5.2.1. Product Type: Ongoing R&D initiatives to promote innovations in the field of monoclonal antibodies
5.2.2. Services: Need for compendial & multi compendial laboratory testing to ensure compliance with regulations
5.2.3. Raw Material Type: Efforts to develop potent APIs to diagnose, cure, or mitigate disease conditions
5.2.4. Application: Changes in lifestyles leading to the need for treatment strategies for cardiovascular diseases
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. Biopharmaceuticals Market, by Product Type
6.1. Introduction
6.2. Monoclonal Antibodies
6.3. Purified Proteins
6.4. Recombinant Growth Factors
6.5. Recombinant Hormone
6.6. Recombinant Proteins
6.7. Synthetic Immunomodulators
6.8. Vaccines
7. Biopharmaceuticals Market, by Services
7.1. Introduction
7.2. Compendial & Multi Compendial Laboratory Testing
7.3. Custom Testing or Customer Proprietary Testing
7.4. Laboratory Testing
8. Biopharmaceuticals Market, by Raw Material Type
8.1. Introduction
8.2. Active Pharmaceutical Ingredient
8.3. Formulation Excipients
9. Biopharmaceuticals Market, by Application
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Cardiovascular Diseases
9.4. Hormonal Disorders
9.5. Immunology
9.6. Inflammatory & Infectious Diseases
9.7. Metabolic Disorders
9.8. Neurological Diseases
9.9. Oncology
10. Americas Biopharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biopharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biopharmaceuticals Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
13.3.2. LEQEMBI Intravenous Infusion (Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20
13.3.3. HHS Announces Details of Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies
List of Figures
FIGURE 1. BIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. BIOPHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BIOPHARMACEUTICALS MARKET DYNAMICS
TABLE 7. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PURIFIED PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT HORMONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SYNTHETIC IMMUNOMODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COMPENDIAL & MULTI COMPENDIAL LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CUSTOM TESTING OR CUSTOMER PROPRIETARY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY FORMULATION EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATORY & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 80. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 121. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 133. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 153. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 157. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 161. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 177. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 189. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 200. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Biopharmaceuticals market, which are profiled in this report, include:
  • AbbVie Inc.
  • Avidea Technologies
  • Bayer AG
  • Thermo Fisher Scientific Inc.
  • Ferring Pharmaceuticals
  • Abbott Laboratories
  • LG Chem Life Sciences Innovation Center, Inc.
  • Ipsen Pharma
  • Novo Nordisk A/S
  • Amgen Inc.
  • BTL Biotechno Labs Pvt. Ltd.
  • Johnson & Johnson Services, Inc.
  • Pfizer, Inc.
  • bioMérieux SA
  • Nordic BioSite
  • GlaxoSmithKline PLC
  • Novartis AG
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Sanofi S.A.
  • Abgenex
  • AstraZeneca PLC
  • F. Hoffmann-La Roche AG
  • Takeda Pharmaceutical Company Limited
  • Bio-Techne Corporation
  • Biogen Inc.

Methodology

Loading
LOADING...

Table Information